  medtron mdt see  earn growth      new york, april  - medtron inc see  growth sale earn year end april , . 
    analyst meet here compani year end april ,  earn  mln dlrs, .-. 
dlr share sale  mln dlrs. 
    year ago period, compani earn . 
mln dlrs, . 
dlr share, sale . 
mln dlrs. 
    winston wallin, medtron chairman, compani improv market share fiscal  cardiac pacemak expand cardiovascular therapeut product line. 
    wallin caution analyst quickli chang per share estim compani medtron heavi sale market expens fiscal . 
    compani intend reinvest earn busi dividends. 
sharehold better grow busi reinvest dividend share repurchases, said. 
    wallin see medtron share total worldwid pacemak market increas  fiscal ,  fiscal . 
    worldwid market cardiovascualr therapeut products, includ pacemakers, valves, cathet lasers, valu . 
billion dlr  doubl . 
    wallin said, object hold new product start build market share beg, borrow steal new markets. 
    past, medtron pacemak plagu number problem lead product recalls. 
regul critic industry, cite qualiti problem needless overprescript pacemakers. 
    knowledg major problem pacemak leads, wallin said. 
intend re-establish compani qualiti leader industry. 
    glen nelson, execut vice presid medtronics, compani intend diversifi intern through acquisit compani area medtron expertise, such drug deliveri systems. 
    wallin  earn growth fiscal  includ dilut acquisitions. 
hope safeti provis wont major dilut acquisition. 
    wallin compani virtual exclus rate respons pacemak fiscal . 
    compani market activitrax, first singl chamber pacemak vari heartrat respons physic activity. 
    siemen ag, west german company, develop rate respons pacemaker.
